Fred Alger Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-18,558
| Closed | -$2.75M | – | 463 |
|
|
2020
Q2 | $2.75M | Buy |
18,558
+1,587
| +9% | +$235K | 0.01% | 287 |
|
|
2020
Q1 | $1.85M | Sell |
16,971
-6,026
| -26% | -$656K | 0.01% | 281 |
|
|
2019
Q4 | $2.65M | Sell |
22,997
-568,973
| -96% | -$65.5M | 0.01% | 277 |
|
|
2019
Q3 | $47.6M | Sell |
591,970
-196,849
| -25% | -$15.8M | 0.19% | 118 |
|
|
2019
Q2 | $57.2M | Buy |
788,819
+371,106
| +89% | +$26.9M | 0.22% | 106 |
|
|
2019
Q1 | $39M | Buy |
417,713
+328,635
| +369% | +$30.7M | 0.16% | 130 |
|
|
2018
Q4 | $6.5M | Sell |
89,078
-40,004
| -31% | -$2.92M | 0.03% | 192 |
|
|
2018
Q3 | $11.3M | Buy |
129,082
+103,829
| +411% | +$9.09M | 0.04% | 178 |
|
|
2018
Q2 | $2.49M | Buy |
+25,253
| New | +$2.49M | 0.01% | 271 |
|
|
2014
Q2 | – | Sell |
-122,969
| Closed | -$8.26M | – | 623 |
|
|
2014
Q1 | $8.26M | Buy |
122,969
+42,556
| +53% | +$2.86M | 0.04% | 318 |
|
|
2013
Q4 | $5.17M | Buy |
+80,413
| New | +$5.17M | 0.03% | 335 |
|